These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 19299310)

  • 1. Congenital muscular dystrophies with defective glycosylation of dystroglycan: a population study.
    Mercuri E; Messina S; Bruno C; Mora M; Pegoraro E; Comi GP; D'Amico A; Aiello C; Biancheri R; Berardinelli A; Boffi P; Cassandrini D; Laverda A; Moggio M; Morandi L; Moroni I; Pane M; Pezzani R; Pichiecchio A; Pini A; Minetti C; Mongini T; Mottarelli E; Ricci E; Ruggieri A; Saredi S; Scuderi C; Tessa A; Toscano A; Tortorella G; Trevisan CP; Uggetti C; Vasco G; Santorelli FM; Bertini E
    Neurology; 2009 May; 72(21):1802-9. PubMed ID: 19299310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Refining genotype phenotype correlations in muscular dystrophies with defective glycosylation of dystroglycan.
    Godfrey C; Clement E; Mein R; Brockington M; Smith J; Talim B; Straub V; Robb S; Quinlivan R; Feng L; Jimenez-Mallebrera C; Mercuri E; Manzur AY; Kinali M; Torelli S; Brown SC; Sewry CA; Bushby K; Topaloglu H; North K; Abbs S; Muntoni F
    Brain; 2007 Oct; 130(Pt 10):2725-35. PubMed ID: 17878207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. POMT1 and POMT2 mutations in CMD patients: a multicentric Italian study.
    Messina S; Mora M; Pegoraro E; Pini A; Mongini T; D'Amico A; Pane M; Aiello C; Bruno C; Biancheri R; Berardinelli A; Boito C; Farina L; Morandi L; Moroni I; Pezzani R; Pichiecchio A; Ricci E; Ruggieri A; Saredi S; Scuderi C; Tessa A; Toscano A; Tortorella G; Trevisan CP; Uggetti C; Santorelli FM; Bertini E; Mercuri E
    Neuromuscul Disord; 2008 Jul; 18(7):565-71. PubMed ID: 18513969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain involvement in muscular dystrophies with defective dystroglycan glycosylation.
    Clement E; Mercuri E; Godfrey C; Smith J; Robb S; Kinali M; Straub V; Bushby K; Manzur A; Talim B; Cowan F; Quinlivan R; Klein A; Longman C; McWilliam R; Topaloglu H; Mein R; Abbs S; North K; Barkovich AJ; Rutherford M; Muntoni F
    Ann Neurol; 2008 Nov; 64(5):573-82. PubMed ID: 19067344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Congenital muscular dystrophy with muscle inflammation alpha dystroglycan glycosylation defect and no mutation in FKRP gene.
    Lamperti C; Cagliani R; Ciscato P; Moroni I; Viri M; Romeo A; Fagiolari G; Prelle A; Comi GP; Bresolin N; Moggio M
    J Neurol Sci; 2006 Apr; 243(1-2):47-51. PubMed ID: 16386759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developmental defects in a zebrafish model for muscular dystrophies associated with the loss of fukutin-related protein (FKRP).
    Thornhill P; Bassett D; Lochmüller H; Bushby K; Straub V
    Brain; 2008 Jun; 131(Pt 6):1551-61. PubMed ID: 18477595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of alpha-dystroglycan glycosylation in dystroglycanopathies suggests that the hypoglycosylation of alpha-dystroglycan does not consistently correlate with clinical severity.
    Jimenez-Mallebrera C; Torelli S; Feng L; Kim J; Godfrey C; Clement E; Mein R; Abbs S; Brown SC; Campbell KP; Kröger S; Talim B; Topaloglu H; Quinlivan R; Roper H; Childs AM; Kinali M; Sewry CA; Muntoni F
    Brain Pathol; 2009 Oct; 19(4):596-611. PubMed ID: 18691338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adeno-associated virus-mediated overexpression of LARGE rescues α-dystroglycan function in dystrophic mice with mutations in the fukutin-related protein.
    Vannoy CH; Xu L; Keramaris E; Lu P; Xiao X; Lu QL
    Hum Gene Ther Methods; 2014 Jun; 25(3):187-96. PubMed ID: 24635668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. POMGnT1, POMT1, and POMT2 mutations in congenital muscular dystrophies.
    Endo T; Manya H; Seta N; Guicheney P
    Methods Enzymol; 2010; 479():343-52. PubMed ID: 20816175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic variations and clinical spectrum of dystroglycanopathy in a large cohort of Chinese patients.
    Song D; Dai Y; Chen X; Fu X; Chang X; Wang N; Zhang C; Yan C; Zheng H; Wu L; Jiang L; Hua Y; Yang H; Wang Z; Dai T; Zhu W; Han C; Yuan Y; Kobayashi K; Toda T; Xiong H
    Clin Genet; 2021 Mar; 99(3):384-395. PubMed ID: 33200426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fukutin mutations in congenital muscular dystrophies with defective glycosylation of dystroglycan in Korea.
    Lim BC; Ki CS; Kim JW; Cho A; Kim MJ; Hwang H; Kim KJ; Hwang YS; Park WY; Lim YJ; Kim IO; Lee JS; Chae JH
    Neuromuscul Disord; 2010 Aug; 20(8):524-30. PubMed ID: 20620061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin alpha2 deficiency and abnormal glycosylation of alpha-dystroglycan.
    Brockington M; Blake DJ; Prandini P; Brown SC; Torelli S; Benson MA; Ponting CP; Estournet B; Romero NB; Mercuri E; Voit T; Sewry CA; Guicheney P; Muntoni F
    Am J Hum Genet; 2001 Dec; 69(6):1198-209. PubMed ID: 11592034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New POMT2 mutations causing congenital muscular dystrophy: identification of a founder mutation.
    Yanagisawa A; Bouchet C; Van den Bergh PY; Cuisset JM; Viollet L; Leturcq F; Romero NB; Quijano-Roy S; Fardeau M; Seta N; Guicheney P
    Neurology; 2007 Sep; 69(12):1254-60. PubMed ID: 17634419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscular dystrophies due to defective glycosylation of dystroglycan.
    Muntoni F; Brockington M; Godfrey C; Ackroyd M; Robb S; Manzur A; Kinali M; Mercuri E; Kaluarachchi M; Feng L; Jimenez-Mallebrera C; Clement E; Torelli S; Sewry CA; Brown SC
    Acta Myol; 2007 Dec; 26(3):129-35. PubMed ID: 18646561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zebrafish models for human FKRP muscular dystrophies.
    Kawahara G; Guyon JR; Nakamura Y; Kunkel LM
    Hum Mol Genet; 2010 Feb; 19(4):623-33. PubMed ID: 19955119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and etiology of congenital muscular dystrophy.
    Peat RA; Smith JM; Compton AG; Baker NL; Pace RA; Burkin DJ; Kaufman SJ; Lamandé SR; North KN
    Neurology; 2008 Jul; 71(5):312-21. PubMed ID: 18160674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in the human LARGE gene cause MDC1D, a novel form of congenital muscular dystrophy with severe mental retardation and abnormal glycosylation of alpha-dystroglycan.
    Longman C; Brockington M; Torelli S; Jimenez-Mallebrera C; Kennedy C; Khalil N; Feng L; Saran RK; Voit T; Merlini L; Sewry CA; Brown SC; Muntoni F
    Hum Mol Genet; 2003 Nov; 12(21):2853-61. PubMed ID: 12966029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Broad spectrum of phenotype and genotype in Korean α-dystroglycan related muscular dystrophy presenting to a tertiary pediatric neuromuscular center.
    Ko YJ; Cho A; Kim WJ; Kim SY; Lim BC; Kim H; Hwang H; Choi JE; Kim KJ; Chae JH
    Neuromuscul Disord; 2023 May; 33(5):425-431. PubMed ID: 37087885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fukuyama congenital muscular dystrophy and related alpha-dystroglycanopathies].
    Murakami T; Nishino I
    Brain Nerve; 2008 Oct; 60(10):1159-64. PubMed ID: 18975603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Congenital muscular dystrophy with glycosylation defects of alpha-dystroglycan in Japan.
    Matsumoto H; Hayashi YK; Kim DS; Ogawa M; Murakami T; Noguchi S; Nonaka I; Nakazawa T; Matsuo T; Futagami S; Campbell KP; Nishino I
    Neuromuscul Disord; 2005 May; 15(5):342-8. PubMed ID: 15833426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.